377 related articles for article (PubMed ID: 28392481)
1. Protein Array-based Approaches for Biomarker Discovery in Cancer.
Huang Y; Zhu H
Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):73-81. PubMed ID: 28392481
[TBL] [Abstract][Full Text] [Related]
2. Discovering cancer biomarkers from clinical samples by protein microarrays.
Hu B; Niu X; Cheng L; Yang LN; Li Q; Wang Y; Tao SC; Zhou SM
Proteomics Clin Appl; 2015 Feb; 9(1-2):98-110. PubMed ID: 25523829
[TBL] [Abstract][Full Text] [Related]
3. New technologies in cancer. Protein microarrays for biomarker discovery.
Matarraz S; González-González M; Jara M; Orfao A; Fuentes M
Clin Transl Oncol; 2011 Mar; 13(3):156-61. PubMed ID: 21421460
[TBL] [Abstract][Full Text] [Related]
4. ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics.
Clarke W; Chan DW
Clin Chem Lab Med; 2005; 43(12):1279-80. PubMed ID: 16309362
[No Abstract] [Full Text] [Related]
5. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
[TBL] [Abstract][Full Text] [Related]
6. [Proteomics and biomarkers for detection of cervical cancer].
Kacerovský M; Tosner J
Ceska Gynekol; 2009 Oct; 74(5):335-8. PubMed ID: 20063836
[TBL] [Abstract][Full Text] [Related]
7. Protein arrays for biomarker discovery.
Reid JD; Parker CE; Borchers CH
Curr Opin Mol Ther; 2007 Jun; 9(3):216-21. PubMed ID: 17608019
[TBL] [Abstract][Full Text] [Related]
8. Reverse phase protein microarrays advance to use in clinical trials.
Mueller C; Liotta LA; Espina V
Mol Oncol; 2010 Dec; 4(6):461-81. PubMed ID: 20974554
[TBL] [Abstract][Full Text] [Related]
9. Antibody microarrays as tools for biomarker discovery.
Sanchez-Carbayo M
Methods Mol Biol; 2011; 785():159-82. PubMed ID: 21901599
[TBL] [Abstract][Full Text] [Related]
10. Emerging nanoproteomics approaches for disease biomarker detection: a current perspective.
Ray S; Reddy PJ; Choudhary S; Raghu D; Srivastava S
J Proteomics; 2011 Nov; 74(12):2660-81. PubMed ID: 21596164
[TBL] [Abstract][Full Text] [Related]
11. Innovative proteomic approaches for cancer biomarker discovery.
Faca V; Krasnoselsky A; Hanash S
Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
[TBL] [Abstract][Full Text] [Related]
12. Antibody arrays--an emerging tool in cancer proteomics.
Kopf E; Zharhary D
Int J Biochem Cell Biol; 2007; 39(7-8):1305-17. PubMed ID: 17600752
[TBL] [Abstract][Full Text] [Related]
13. Antibody arrays: technical considerations and clinical applications in cancer.
Sanchez-Carbayo M
Clin Chem; 2006 Sep; 52(9):1651-9. PubMed ID: 16809399
[TBL] [Abstract][Full Text] [Related]
14. Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.
Lu Y; Ling S; Hegde AM; Byers LA; Coombes K; Mills GB; Akbani R
Semin Oncol; 2016 Aug; 43(4):476-83. PubMed ID: 27663479
[TBL] [Abstract][Full Text] [Related]
15. Proteomic Approaches for Biomarker Panels in Cancer.
Tanase C; Albulescu R; Neagu M
J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
[TBL] [Abstract][Full Text] [Related]
16. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis.
Wright GL
Expert Rev Mol Diagn; 2002 Nov; 2(6):549-63. PubMed ID: 12465452
[TBL] [Abstract][Full Text] [Related]
17. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
18. Clinical proteomics for cancer biomarker discovery and therapeutic targeting.
Krieg RC; Paweletz CP; Liotta LA; Petricoin EF
Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785
[TBL] [Abstract][Full Text] [Related]
19. Protein microarrays for cancer diagnostics and therapy.
Lin JC
Med Princ Pract; 2010; 19(4):247-54. PubMed ID: 20516699
[TBL] [Abstract][Full Text] [Related]
20. Discovery of biomarkers for gastric cancer: a proteomics approach.
Lin LL; Huang HC; Juan HF
J Proteomics; 2012 Jun; 75(11):3081-97. PubMed ID: 22498886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
